Background. Accidental intrathecal injection of bupivacaine during epidural analgesia in labour remains a hazard, with the potential to cause total spinal anaesthesia and maternal collapse. Sacral block appears early after intrathecal injections compared with epidural ones, and we therefore used SI motor block to determine a safe and reliable test dose for epidural catheter misplacement.
The accidental intrathecal injection of bupivacaine during intrathecal injection and is the last dermatome to be affected epidural analgesia in labour remains a hazard, with the after an epidural injection. Yarnell and colleagues 1 showed potential to cause total spinal anaesthesia and maternal that after 10 ml of 0.25% bupivacaine, only 3% of mothers collapse. The main features, which are said to distinguish had SI motor blockade, between epidural and intrathecal injection, are rapid analgesia, excessive sensory block, early sacral block, intense motor block and hypotension in the latter. There have been Methods no specific tests that have been shown to reliably differen-With full local research ethics committee approval and tiate between the two sites of administration.
patient written informed consent, we recruited mothers who This study was designed to evaluate the use of SI motor were booked for elective Caesarean section at term with a block as a reliable and easily reproducible clinical sign that singleton foetus. The anaesthetic technique was a combined will differentiate between an epidural injection and an spinal epidural (CSE). Exclusion criteria included maternal accidental subarachnoid injection for labour analgesia.
refusal, contraindications to regional technique, multiple We used SI motor block as our clinical test because pregnancy and complicated medical history including during epidural anaesthesia there is a sequence of motor pregnancy-induced hypertension. blockade, starting with an early lumbar motor block I.v. access and routine monitoring were established in the involving hip flexion, and then extending to a sacral anaesthetic room. The non-invasive arterial pressure cuff motor block involving the plantar flexion of the foot. In was set for a 2-min recording cycle. I.v. fluids were infused spinal anaesthesia, early sacral anaesthesia is characteristic, before and during the anaesthetic (Hartmann's solution In other words, SI blockade appears early after an 500-1000 ml). The CSE technique was performed in the sitting position at the L3-4 interspace, a standard 16 gauge Tuohy needle was inserted into the epidural space using loss of resistance to air and a 119 mm 27 gauge Becton-Dickinson pencilpoint spinal needle was inserted through the epidural needle once the epidural space was located. After injection of the study mixture, the spinal needle was withdrawn and the epidural catheter was inserted. The Tuohy needle was then removed and the mother placed in the full right lateral position. After 5 min, the block was assessed and the mother turned supine with a 15° left lateral tilt. At 10 min, the block was tested again.
The loss of resistance to air was used to increase the reliability of detecting that the intrathecal dose was injected into the subarachnoid space, rather than being misplaced in the epidural space. The CSE technique had to be technically perfect with free flow of cerebrospinal fluid seen at the first pass of the spinal needle and no spillage of the spinal anaesthetic on injection, for the patient to remain in the study.
Arterial pressure was monitored non-invasively on a 2-min cycle and ephedrine was used in 6-mg i.v. boluses if the mother felt light-headed or nauseous or if her arterial pressure fell by 20% from her pre-block base line.
The study was divided into two parts. The first part was to determine the ED50 of SI motor block, 10 min after spinal injection. The drugs used were 0.25% bupivacaine with fentanyl in a fixed ratio of bupivacaine 1 mg to fentanyl 2 (ig. We chose this drug combination to mimic the bupivacaine-fentanyl mixture that is in common use as an epidural solution for labour analgesia. The first patient in the study was given intrathecal bupivacaine 3 mg with fentanyl 6 LLg. At 10 min there was no SI motor block (nonresponder), and the next patient in the study received 4 mg and so on until the next patient did have SI motor block (responder) ( Table 1 ). The next patient after a responder received bupivacaine 1 mg and fentanyl 2 |ig less, while the next patient after a non-responder received bupivacaine 1 mg and fentanyl 2 Lig more. From this up-down sequential allocation, the ED 50 for SI motor block at 10 min was calculated after 20 patients.
After the 10-min initial study period, the assessor decided if the block was adequate for Caesarean section. An adequate block was considered to be a T4-S1 temperature block and a T6-S1 light touch block, together with a dense motor lumber-sacral block. If the block was inadequate, increments of 0.5% bupivacaine 5 ml were injected into the epidural space at 5-min intervals until a satisfactory block was obtained, and epidural morphine 4 mg given for postoperative analgesia.
The plan for the second part of the study was to use a fixed dose equal to roughly twice the ED 50 , derived from part one of the study, in 60 patients. The choice of twice the ED 50 was based on the rule-of-thumb that sensitivity to injected drugs amongst the population ranges from half the ED50 to twice the ED50 The number 60 was chosen on the grounds that if r patients did not respond, where r was zero or very small, the upper 95% confidence limit of nonresponders 2 would be between approximately r+3 and r+6 out of 60, i.e. an uncertainty of 5-10%. In fact, 62 mothers were given bupivacaine 13 mg (plain 0.5% bupivacaine with 26 jig of fentanyl) using the CSE technique. We chose 13 mg rather than 14 mg because we did not want to deviate too far from our routine practice of bupivacaine 12.5 mg and fentanyl 25 |lg for elective Caesarean section. SI motor block was assessed at 10 min, as before. Epidural morphine was given for postoperative analgesia.
Results
Applying the formula of Dixon and Massey 3 to the 20 patients in the first part of the study showed that the ED50 for SI motor block at 10 min was bupivacaine 7.0 mg with fentanyl (95% CI, 6.2-7.8) (Fig. 1) .
In the second part of the study all the 62 patients given bupivacaine 13 mg with fentanyl had SI motor block 10 min after intrathecal injection. Therefore, on the basis of those patients alone, the estimated incidence of non-responders to a dose of 13 mg is 0 with an upper 95% confidence limit 2 of 3.6 in 62 patients i.e. a 2.5% risk that 6% of patients will not respond to 13 mg.
Logistic regression analysis 45 of the results for all 82 patients made use of all the data. This confirmed the Dixon Massey result, ED 50 being 7.0 mg (95% CI, 6.2-7.8) with an estimated ED 95 of 9.1 mg (95% CI, 8.2-10.6) and ED 9 7 5 of 9.7 mg (95% CI, 8.7-11.4) (Fig. 2) .
Differences between the characteristics of the blocks and haemodynamic stability were seen after the two parts of the study. Statistical analysis was not performed because the groups were not randomized and are of unequal size. The data from patient number one has also been excluded from this part of the analysis, as she required ephedrine 39 mg following the smallest intrathecal dose of bupivacaine 3 mg, by far the largest dose of ephedrine of any patient in any part of the study.
Fifty per cent of mothers in the first part required ephedrine with an average dose of 13.6 mg, whilst 75% of mothers in the second part of the study required on average 17.3 mg. Nine of 10 mothers who developed hypotension in part one of the study, did so after the spinal injection and then tended to need more ephedrine during the epidural topups to maintain arterial pressure. Only one mother needed a small 6-mg dose of ephedrine after her epidural top-up; she did not require ephedrine after her intrathecal injection. A wide dose range of epidural 0.5% bupivacaine was given to supplement the intrathecal injection (0-25 ml (0-125 mg)), and the mean time to establish the final block height was 25 min (range 15-50 min).
There were no excessive sensory blocks at final block assessment just before surgery commenced in the first part of the study, where a maximum intrathecal dose of bupivacaine 9 mg was used, followed by incremental epidural top-ups. There was, however, an 8% incidence of a sensory block to ice at C6 or above, and a 14% incidence of block to light touch at T2 and above, in part two of the study where only the higher dose intrathecal injection was given ( Table 2) .
Discussion
This study has determined a safe test-dose that can be used in the obstetric population to reliably detect, after 10 min, a top-up that was intended for the epidural space but has been given intrathecally. A combination of rapid sensory block, motor block, hypotension and analgesia has previously alerted anaesthetists to the possibility of accidental intrathecal injection, but the reliability and discrimination of these tests has never been determined, and neither has the best and most discriminative time period for making an evaluation been assessed. This study has looked at only one element i.e. SI motor blockade, to allow reliable early detection. We found that there is a very steep dose response curve for SI motor block and that bupivacaine 13 mg was in excess of the ED975. There was also a significant incidence of high sensory blockade and hypotension using bupivacaine 13 mg, which could pose a problem if it occurred in a delivery room rather than theatre. Historically, the test dose contained a mixture of low volume high dose local anaesthetic and a vasoconstrictor. The vasoconstrictor was used as an indicator of an accidental intravascular injection. 6 A vasoconstrictor has never been shown to be very predictive of an intravascular injection and careful aspiration of the epidural catheter has now taken its place. The high concentration, low volume local anaesthetic that has traditionally been used, aimed to identify an accidental subarachnoid block before a high volume, high concentration local anaesthetic was given into the epidural space.
It was suggested that an epidural test dose should be mandatory 7 and Kumar and colleagues 8 recommended the use of 1.5 ml of 0.5% bupivacaine (7.5 mg). Prince and colleagues 910 suggested 1.6 ml of 0.5% bupivacaine (8 mg) plus 10 min waiting time in order to avoid false negative tests. Others 11 recommended more than 10 yr ago that 10 ml of 0.125% bupivacaine (12.5 mg) is a safe and effective test dose. A review of the literature shows that obstetric anaesthetists use a wide range of test doses on initial epidural placement 12 and previous research has suggested a number of regimen ranging from 1.5% lidocaine 3 ml (45 mg) to 0.5% bupivacaine 3 ml (15 mg). No research has been able to demonstrate the safety and reliability profile of any of these regimen, or the exact test that should be performed.
It is now accepted that the main determinant of a socalled test dose is the actual dose of local anaesthetic injected in the epidural space. In other words, it has been shown that when injected intrathecally, 0.1% bupivacaine 10 ml (10 mg) results in the same spread and intensity as 2 ml of 0.5% bupivacaine (10 mg). 13 Therefore, the use of low volume, high concentration test doses are not necessary.
Another potential danger of epidural analgesia in labour is that accidental intrathecal injection has been reported many hours after an apparently uneventful epidural block. Obstetric anaesthetists use epidural boluses of 5-50 mg of bupivacaine for labour pain.
11 This wide range of doses would produce widely differing clinical pictures if the catheter migrated into the subarachnoid space. The use of 10-mg top-ups can therefore be recommended for use throughout labour as they give reliable analgesia 14 with a margin of safety. Routine assessment of the mother's ankle plantar flexion can be taught to anyone giving the top-ups, allowing early detection of catheter migration. We feel that it would remain a valuable test even if there were some hip flexion weakness.
A spin off from our study design was a comparison between low dose spinal anaesthetics followed by epidural top-ups and high dose spinal anaesthesia for Caesarean section. There was improved haemodynamic stability in the low dose group and fewer high blocks. The spinal blocks were easily supplemented by 0.5% epidural bupivacaine in the epidural space and in most cases there was only a few minutes increase in preparation time. We now use the low dose spinal anaesthetic technique with epidural top-ups, if reducing the risk of hypotension in the mother is important and there is no hurry to establish anaesthesia.
This study looked at only one element, i.e. SI motor block, to allow reliable early detection of accidental intrathecal injection. Although we do not know what the incidence of SI motor block is after bupivacaine 10 mg in the epidural space, we can assume it is very low as only 3% had SI blockade after 25 mg of bupivacaine epidurally. 1 We found that there was a very steep dose response curve for S1 motor block. The ED 9 7 5 of 9.7 mg (95% CI, 8.7-11.4) approaches the result required for a reliable predictive test. Our initial guess of an ED 95 from the ED 50 of approximately double the dose of bupivacaine grossly over-estimated the result. Individual doses of 13 mg, used in the second part of the study, would be more reliable, but there was a high requirement for ephedrine with a high incidence of excessive sensory and motor blockade. We recognize that the addition of fentanyl may have altered our results and that bupivacaine alone may have a different ED 97 5 , but we felt justified in our study design because an opioid is very commonly added to bupivacaine for labour analgesia.
We therefore recommend that epidural analgesia can be initiated with an epidural dose of bupivacaine 10 mg in a 0.1% concentration with fentanyl, followed by testing for SI motor block at 10 min. Assessing the sensory spread of the block and the mother's arterial pressure also remains important. If the test dose is negative, the same dose can be used to establish and then maintain full analgesia in labour as required.
